Compare · CI vs CLOV
CI vs CLOV
Side-by-side comparison of The Cigna Group (CI) and Clover Health Investments Corp. (CLOV): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CI and CLOV operate in Medical Specialities (Health Care), so they compete in similar markets.
- CI is the larger of the two at $74.55B, about 52.3x CLOV ($1.42B).
- Over the past year, CI is down 15.3% and CLOV is down 18.7% - CI leads by 3.5 points.
- CI has been more active in the news (18 items in the past 4 weeks vs 15 for CLOV).
- CI has more recent analyst coverage (25 ratings vs 12 for CLOV).
- Company
- The Cigna Group
- Clover Health Investments Corp.
- Price
- $283.05-2.62%
- $2.71-1.45%
- Market cap
- $74.55B
- $1.42B
- 1M return
- +5.89%
- +58.48%
- 1Y return
- -15.26%
- -18.74%
- Industry
- Medical Specialities
- Medical Specialities
- Exchange
- NYSE
- NASDAQ
- IPO
- News (4w)
- 18
- 15
- Recent ratings
- 25
- 12
The Cigna Group
Cigna Corporation provides insurance and related products and services in the United States. Its Evernorth segment provides a range of coordinated and point solution health services, including pharmacy, benefits management, care, and intelligence solutions to health plans, employers, government organizations, and health care providers. The company's U.S. Medical segment offers commercial products and services, including medical, pharmacy, behavioral health, dental, vision, health advocacy programs, and other products and services for insured and self-insured customers; Medicare Advantage, Medicare Supplement, and Medicare Part D plans for seniors, as well as Medicaid plans; and individual health insurance plans to on and off the public exchanges. Its International Markets segment offers health coverage, hospitalization, dental, critical illness, personal accident, term life, medical cost containment, and variable universal life products, as well as health care benefits to mobile employees of multinational organizations. The company distributes its products and services through insurance brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was founded in 1792 and is headquartered in Bloomfield, Connecticut.
Clover Health Investments Corp.
Clover Health Investments, Corp. operates as a Medicare Advantage insurer in the United States. The company through its software platform provides preferred provider organization and health maintenance organization health plans for Medicare-eligible consumers. Clover Health Investments, Corp. was founded in 2014 and is headquartered in Franklin, Tennessee.
Latest CI
- SEC Form 10-Q filed by The Cigna Group
- The Cigna Group filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- The Cigna Group Reports Strong First Quarter 2026 Results, Raises 2026 Outlook
- The Cigna Group filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
- Director Foss Eric J was granted 782 shares, increasing direct ownership by 2% to 36,696 units (SEC Form 4)
- Director Mcclellan Mark B. was granted 782 shares, increasing direct ownership by 13% to 6,891 units (SEC Form 4)
- Director Zarcone Donna F was granted 782 shares, increasing direct ownership by 3% to 27,517 units (SEC Form 4)
- Director Hathi Neesha was granted 782 shares, increasing direct ownership by 23% to 4,151 units (SEC Form 4)
- Director Mazzarella Kathleen M was granted 782 shares, increasing direct ownership by 13% to 6,891 units (SEC Form 4)
- Director Kurian George was granted 782 shares, increasing direct ownership by 21% to 4,560 units (SEC Form 4)
Latest CLOV
- SEC Form DEFA14A filed by Clover Health Investments Corp.
- SEC Form DEF 14A filed by Clover Health Investments Corp.
- SEC Form 4 filed by Priest Brady Patrick
- SEC Form 4 filed by Priest Brady Patrick
- SEC Form 4 filed by Soares Karen
- SEC Form 4 filed by Toy Andrew
- SEC Form 4 filed by Thornton Joseph Clay
- SEC Form 4 filed by Reynoso Jamie L.
- SEC Form 4 filed by Wai Conrad
- SEC Form 3 filed by new insider Oldakowski Joseph Frank